GHW International (HK:9933) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
GHW International’s subsidiary, Nanjing Happyelephant Health Technology, has secured an exclusive distribution agreement with Swisscoat Vision to market innovative optical lenses in Jiangsu province, China, starting in 2025. This strategic partnership aims to enhance the availability of specialized lenses for visually impaired individuals, featuring advancements like low vision rehabilitation and medical photosensitive filter lenses. The agreement highlights GHW’s commitment to expanding its footprint in the advanced medical products sector.
For further insights into HK:9933 stock, check out TipRanks’ Stock Analysis page.